Health Condition 1: N979- Female infertility, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
other
Eligibility
Inclusion criteria
Inclusion criteria: controlled ovarian stimulation with a GnRH antagonist protocol
Exclusion criteria
Exclusion criteria: uterine abnormalities, severe male factor infertility, or donor oocyte cycles
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the association between elevated progesterone levels and oocyte and embryo quality in IVF cycles.Timepoint: 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| To analyze fertilization rates based on progesterone levels. To assess embryo development at cleavage and blastocyst stages. To assess the impact on clinical pregnancy rates. To explore potential mitigation strategies for optimizing IVF outcomes in patients with elevated progesterone levels.Timepoint: 1 month | — |
Countries
India
Contacts
Public ContactDr Aparna Das
A4 Hospitals and Fertility centre Pvt Ltd
Outcome results
None listed